SBRT + PD-1 Antibody in Unresectable Locally Recurrent Rectal Cancer（SPARKLE）
SBRT + PD-1 Antibody in Unresectable Locally Recurrent Rectal Cancer（SPARKLE）
Recruiting · NCT06767007 · Registry updated 2026-04-23Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| SBRT + PD-1 Antibody in Unresectable Locally Recurrent Rectal Cancer（SPARKLE） | Unresectable Locally Recurrent Rectal Cancer | Recruiting | Phase 2 | 2026-04-23 | NCT06767007 |
5 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Fudan University | 653 |
| Shenzhen People's Hospital | 35 |
| Sixth Affiliated Hospital, Sun Yat-sen University | 122 |
| Sun Yat-Sen University Cancer Center | 74 |
| Yunnan Cancer Hospital | 46 |
1 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Sixth Affiliated Hospital, Sun Yat-sen University | Guangzhou | China | 3 |